Novacyt

{{short description|Anglo-French biotechnology group}}

{{Infobox company

|logo = File:Novacyt logo.jpg

|name = Novacyt S.A.

|type = Société Anonyme

|traded_as = {{LSE|NCYT}}
{{euronext|ALNOV}}

|foundation = 2006

|location = Camberley, Surrey, United Kingdom

|key_people = David Allmond (CEO)

|industry = Biotechnology

|products = In vitro and molecular diagnostics

| subsid = {{ubl

| Primerdesign

}}

|homepage = [https://novacyt.com/ www.novacyt.com]

|num_employees =

}}

Novacyt Group ({{IPAc-en|ˈ|n|oʊ|v|ə|s|aɪ|t}} {{Respell|NOH|və|syte}}) is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France.{{cite web |title=Offices |url=https://novacyt.com/contact-us/ |website=Novacyt |accessdate=1 February 2020}}{{cite web |title=How dangerous is the coronavirus and how does it spread? |url=https://www.ft.com/content/ed3fb63e-41ce-11ea-bdb5-169ba7be433d |website=Financial Times |accessdate=1 February 2020}} The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide.{{cite web |title=Novacyt launches research-only Wuhan virus test |url=https://www.thestandard.com.hk/breaking-news/section/3/141013/Novacyt-launches-Wuhan-virus-test |website=The Standard (Hong Kong) |accessdate=1 February 2020}} Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.{{cite web |title=Annual Report and Accounts for the year ended December 2018 |url=http://novacyt.com/wp-content/uploads/2019/06/7900_Novacyt_2019-Financial-Report_Web.pdf |website=Novacyt |accessdate=1 February 2020}}

In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV.{{cite web |title=Healthcare Company Novacyt Launches New Coronavirus Test |url=https://www.nytimes.com/reuters/2020/01/31/world/europe/31reuters-china-health-novacyt.html |website=The New York Times |accessdate=1 February 2020}}{{cite web |title=Novacyt shares jump 32% on launch of coronavirus test |url=https://www.cnbc.com/2020/01/31/novacyt-shares-jump-32percent-on-launch-of-coronavirus-test.html |website=CNBC |date=31 January 2020 |accessdate=1 February 2020}}{{cite web |title=Chandlers Ford company Primerdesign launch novel coronavirus test |url=https://www.dailyecho.co.uk/news/18201164.chandlers-ford-company-primerdesign-launch-novel-coronavirus-test/ |website=Southern Daily Echo |date=31 January 2020 |accessdate=1 February 2020}}{{cite web |title=Novacyt in prime position with coronavirus test |url=https://www.thetimes.com/uk/healthcare/article/novacyt-in-prime-position-with-coronavirus-test-z03xm556b |website=The Times |date=8 February 2020 |access-date=8 February 2020}} The test was approved as eligible for procurement under the World Health Organization's (WHO) Emergency Use Listing process in April 2020,{{cite web |title=WHO approves Novacyt's coronavirus testing kit |url=https://www.jpost.com/breaking-news/who-approves-novacyts-coronavirus-testing-kit-624012 |website=The Jerusalem Post |date=8 April 2020 |accessdate=8 April 2020}} meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response.{{cite web |title=WHO lists two COVID-19 tests for emergency use |url=https://www.who.int/news-room/detail/07-04-2020-who-lists-two-covid-19-tests-for-emergency-use |website=World Health Organization |accessdate=10 April 2020}} In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory.{{cite web |title=Novacyt's Covid-19 diagnostic test gets OK for WHO procurement |url=https://www.lse.co.uk/news/novacyt-s-covid-19-diagnostic-test-gets-ok-for-who-procurement-xja8we229j2ws7t.html |website=London South East |accessdate=8 April 2020}}{{cite web |title=Novacyt joins AstraZeneca and GSK in UK effort on COVID-19 testing |url=https://www.thepharmaletter.com/article/novacyt-joins-astrazeneca-and-gsk-in-uk-effort-on-covid-19-testing |website=The Pharma Letter |accessdate=8 April 2020}}